| Abstrakt: |
Researchers from Northeastern University have highlighted the importance of nanomedicine in addressing the unique challenges of diagnosing and treating pediatric diseases. Traditional drugs often require adjustments in pediatric patients, leading to suboptimal outcomes and increased risks of adverse effects. Nanomedicines, with their unique properties, offer efficient drug delivery systems that can improve drug solubility and stability. This review emphasizes the potential of nanomedicines in pediatric therapy and discusses FDA-approved applications and preclinical studies that may translate to clinical practice. [Extracted from the article] |
